Monday, April 01, 2019 7:29:03 PM
As a follow up to my post# 47745,you can sell your ACB shares at anytime no obligation on your part for a time limit, you still own them.
Also for Aurora bought on margin, when a client opens a margin account, there is usually a clause in the contract that states that the broker is authorized to lend—either to itself or to others—any securities held by the client. By signing this agreement, the client forgoes any future benefit of having their shares lent out to other parties.
it is now confirmed you can sell anytime.
LINK:
https://www.investopedia.com/ask/answers/05/shortsalebenefit.asp
The borrowed shares may be coming out of another trader's margin account, out of the shares being held in the broker's inventory, or even from another brokerage firm. It is important to note that, once the transaction has been placed, the broker is the party doing the lending and not the individual investor. So, any benefit received (along with any risk) belongs to the broker.
The broker does receive an amount of interest for lending out the shares, and it is also paid a commission for providing this service. In the event that the short seller is unable (due to a bankruptcy, for example) to return the shares he or she borrowed, the broker is responsible for returning the borrowed shares. While this is not a huge risk to the broker due to margin requirements, the risk of loss is still there, and this is why the broker receives the interest on the loan.
In the event that the lender of the shares wishes to sell the stock, the short seller is generally not affected. The brokerage firm that loaned out the shares from one client's account to a short seller will usually replace the shares from its existing inventory. The shares are sold and the lender receives the proceeds of the sale into their account. The brokerage firm is then owed the shares by the short seller.
Also for Aurora bought on margin, when a client opens a margin account, there is usually a clause in the contract that states that the broker is authorized to lend—either to itself or to others—any securities held by the client. By signing this agreement, the client forgoes any future benefit of having their shares lent out to other parties.
it is now confirmed you can sell anytime.
LINK:
https://www.investopedia.com/ask/answers/05/shortsalebenefit.asp
The borrowed shares may be coming out of another trader's margin account, out of the shares being held in the broker's inventory, or even from another brokerage firm. It is important to note that, once the transaction has been placed, the broker is the party doing the lending and not the individual investor. So, any benefit received (along with any risk) belongs to the broker.
The broker does receive an amount of interest for lending out the shares, and it is also paid a commission for providing this service. In the event that the short seller is unable (due to a bankruptcy, for example) to return the shares he or she borrowed, the broker is responsible for returning the borrowed shares. While this is not a huge risk to the broker due to margin requirements, the risk of loss is still there, and this is why the broker receives the interest on the loan.
In the event that the lender of the shares wishes to sell the stock, the short seller is generally not affected. The brokerage firm that loaned out the shares from one client's account to a short seller will usually replace the shares from its existing inventory. The shares are sold and the lender receives the proceeds of the sale into their account. The brokerage firm is then owed the shares by the short seller.
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2026 12:44:17 PM
- Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science • PR Newswire (Canada) • 05/14/2026 10:54:00 AM
- Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science • PR Newswire (US) • 05/14/2026 10:54:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 12:15:03 PM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (US) • 04/28/2026 10:53:00 AM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (Canada) • 04/28/2026 10:53:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2026 08:18:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 11:21:53 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (US) • 04/15/2026 11:05:00 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (Canada) • 04/15/2026 11:05:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 11:29:57 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (US) • 03/30/2026 11:03:00 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (Canada) • 03/30/2026 11:03:00 AM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (Canada) • 02/17/2026 11:39:00 PM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (US) • 02/17/2026 11:39:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:26:03 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (Canada) • 02/12/2026 09:05:00 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (US) • 02/12/2026 09:05:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (Canada) • 02/11/2026 12:00:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:44:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 02:45:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:27:19 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 02/04/2026 12:10:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:05:38 PM
